CGMA CPA - Soligenix CFO VP
| SNGX Stock | USD 2.40 0.05 2.13% |
Insider
CGMA CPA is CFO VP of Soligenix
| Age | 53 |
| Phone | 609 538 8200 |
| Web | https://www.soligenix.com |
Soligenix Management Efficiency
The company has return on total asset (ROA) of (0.4514) % which means that it has lost $0.4514 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.398) %, meaning that it created substantial loss on money invested by shareholders. Soligenix's management efficiency ratios could be used to measure how well Soligenix manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| DSc MSE | Immix Biopharma | 75 | |
| James JD | Allarity Therapeutics | 55 | |
| Robert McRae | Palisade Bio | N/A | |
| MBA MD | Immix Biopharma | 49 | |
| Xiaoqin MD | Avenue Therapeutics | 49 | |
| Roger MD | Addex Therapeutics | 68 | |
| Professor MD | Allarity Therapeutics | 67 | |
| MD DrSc | Allarity Therapeutics | 81 | |
| Sharon McBrayer | Palisade Bio | N/A | |
| Annie Rasmussen | Allarity Therapeutics | 67 | |
| Robert Lutjens | Addex Therapeutics | 56 | |
| Geoffrey Birkett | Ensysce Biosciences | 62 | |
| Werner Henrichi | Addex Therapeutics | 81 | |
| David Hale | Dermata Therapeutics | 76 | |
| Tracy Rarick | Windtree Therapeutics | N/A | |
| Ronald Dundore | Windtree Therapeutics | 69 | |
| Jeffrey Millard | Ensysce Biosciences | 49 | |
| John CPA | Windtree Therapeutics | 60 | |
| JD MBA | Immix Biopharma | N/A | |
| David Jin | Avenue Therapeutics | 35 | |
| Diane Esq | Windtree Therapeutics | 55 | |
Management Performance
| Return On Equity | -1.4 | ||||
| Return On Asset | -0.45 |
Soligenix Leadership Team
Elected by the shareholders, the Soligenix's board of directors comprises two types of representatives: Soligenix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Soligenix. The board's role is to monitor Soligenix's management team and ensure that shareholders' interests are well served. Soligenix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Soligenix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oreola Donini, Chief Scientific Officer and Sr. VP | ||
| Christopher Schaber, Chairman, CEO and Pres | ||
| Richard Dunning, Ex Officer | ||
| CGMA CPA, CFO VP | ||
| MSc MD, Senior Officer |
Soligenix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Soligenix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.4 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (21.60) % | ||||
| Current Valuation | (1.74 M) | ||||
| Shares Outstanding | 2.51 M | ||||
| Shares Owned By Insiders | 0.02 % | ||||
| Shares Owned By Institutions | 2.63 % | ||||
| Number Of Shares Shorted | 14.55 K | ||||
| Price To Earning | (1.67) X | ||||
| Price To Book | 0.99 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Soligenix Stock Analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.